Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Salarius Pharmaceuticals Issued U.S. Patent No. 11,773,080 Titled "Deuterium-Enriched Isoindolinonyl-Azepanediones And Related Compounds And Methods Of Treating Medical Disorders Using Same"

Author: Benzinga Newsdesk | January 16, 2024 09:16am

Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues

Protein degrader portfolio now includes 17 issued patents across six patent families

Posted In: SLRX